Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 390 a 409 di 498
Titolo Data di pubblicazione Autore(i) File
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET 2016 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Laurenti, L; Zallio, F; Marchetti, M; Ruggeri, M; Omede, P; Ferretti, A; Del Poeta, G; Mauro, FR; Foa, R; Gattei, V; Gaidano, G; Boccadoro, M; Massaia, M; Coscia, M
REGULATION OF HIF-1 IN TP53 DISRUPTED CLL CELLS AND ITS INHIBITION AS A STRATEGY TO OVERCOME FLUDARABINE RESISTANCE 2017 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, FR; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M
Renal enlargement and prognosis of acute lymphoblastic leukemia in children: absence of correlations 1984 Pastore G; Saracco P; Miniero R; Artesani L; Listello G; Cordero di Montezemolo L; Madon E; Nicola P.
Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, November 3-7, 1993. 1994 LANZA F ;MORETTI S ;PAPA S ;MALAVASI F ;CASTOLDI G
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain 2007 SOVERINI S; COLAROSSI S; GNANI A; CASTAGNETTI F; ROSTI G; BOSI C; PAOLINI S; RONDONI M; PICCALUGA PP; PALANDRI F; GIANNOULIA P; MARZOCCHI G; LUATTI S; TESTONI N; IACOBUCCI I; CILLONI D; SAGLIO G; BACCARANI M; MARTINELLI G
RESULTS OF "REAL-LIFE" FRONTLINE DASATINIB TREATMENT IN UNSELECTED ELDERLY PATIENTS WITH CHRONIC MYELOID LEUKEMIA 2014 Latagliata, R; Stagno, F; Annunziata, M; Iurlo, A; Scappini, B; Guarini, A; Giglio, G; Fava, C; Sora, F; Capodanno, I; Crugnola, M; Crescenzi, Sl; Barsotti, S; Feo, C; Breccia, M; Vigneri, P; Cambrin, Gr; Gozzini, A; Alimena, G
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients. 1996 LEVIS A ;DEPAOLI L ;BERTINI M ;BOTTO B ;CIRAVEGNA G ;FREILONE R ;GALLAMINI A ;GAVAROTTI P ;RICARDI U ;SCALABRINI DR ;SALOMONE A ;SALVI F ;VITOLO U ;PILERI A ;SANNAZZARI GL ;RESEGOTTI L
Retrospective analysis of 260 patients with essential thrombocythemia: iwg-mrt (ipset model; passamonti et al, blood 2012) prognostic score is a good predictor of survival 2014 Benevolo, G.; Nicolino, B.; Beggiato, E.; Frairia, C.; Evangelista, A.; Pirillo, F.; Manzini, Pm.; Riera, L.; Aguzzi, C.; Vitolo, U
Retrospective analysis of the long term safety of lenalidomide (Len)±dexamethasone (Dex) in relapsed/refractory multiple myeloma (RRMM) patients (pts): analysis of pooled data and incidence rates (IR) of second primary malignancy (SPM) 2011 G MORGAN; B DURIE; J SAN MIGUEL; R ORLOWSKI; S LONIAL; A PALUMBO; R NIESVIZKY; R BAZ; S GIRALT; W BENSINGER; N BRANDENBURG; Z YU; M BOCCADORO; P RICHARDSON; K ANDERSON; B BARLOGIE
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia. 2003 ROSTI G; TRABACCHI E; BASSI S; BONIFAZI F; DE VIVO A; MARTINELLI G; ALBERTI; D; FINCATO G; G. SAGLIO; BACCARANI M; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC; MYELOID LEUKEMIA.
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 2001 GUGLIELMI C ;MARTELLI M ;FEDERICO M ;ZINZANI PL ;VITOLO U ;BELLESI G ;SANTINI G ;TARELLA C ;ZALLIO F ;PREGNO P ;DI RENZO N ;RESEGOTTI L
ROCK AS THERAPEUTICAL TARGET FOR MORGANA LOW CML 2016 S Rocca, A Di Savino, C Panuzzo, U Familiari, G Saglio, A Morotti, M Brancaccio
Role of a hematopoietic stem cell transplant registry in childhood: the experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) 2002 Pession, Andrea; Rondelli, Roberto; Locatelli, Franco; Dini, Giorgio; Fagioli, Franca; Messina, Chiara; de Rosa, Marisa; Uderzo, Cornelio
ROLE OF ALLOGRAFTING IN ACUTE LYMPHOBLASTIC LEUKEMIA: A 12 YEAR EXPERIENCE 2013 Giaccone L; Bruno B; Maffini E; Audisio E; D'Ardia S.; Caracciolo D; Allione D; Busca A.; Ferrando F; Testa F; Festuccia M.; Brunello L; Boccadoro M; Vitolo U; Passera R.; Falda M; Marmont F
ROLE OF ALLOGRAFTING IN HIGH RISK ACUTE MYELOID LEUKEMIA 2013 Bruno Benedetto; Audisio E; D'Ardia ; Ferrero ; Maffini ; Giaccone Luisa; Allione; Busca; Della Casa; Testa; Frairia; Ferrando; Festuccia ; Brunello; Evangelista ; Boccadoro Mario; Vitolo; Ciccone; Falda; Marmont
ROLE OF HAUSP/PTEN NETWORK IN CHRONIC LYMPHOID LEUKEMIA PATHOGENESIS AND THERAPY 2015 G. Carrà, C. Panuzzo, D. Torti, G. Parvis, S. Crivellaro, A. Guerrasio, G. Saglio, A. Morotti
The role of targeted treatment in mantle cell lymphoma: Is transplant dead or alive? 2016 Ferrero, Simone
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 2004 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 2010 Boggio E; Indelicato M; Orilieri E; Mesturini R; Mazzarino MC; Campagnoli MF; Ramenghi U; Dianzani U; Chiocchetti A
SAFETY AND EFFICACY OF BORTEZOMIB IN RELAPSED MULTIPLE MYELOMA FOLLOWING REDUCED INTENSITY/NONMYELOABLATIVE CONDITIONINGS AND ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION 2006 L. Giaccone; R. Sorasio; F. Patriarca; D. Mattei; P. Corradini; V. Montefusco; J. Peccatori; R. Fanin; F. Carnevale-Schianca; S. Guidi; M.T. Petrucci; G. Milone; M. Rotta; B. Bruno; M. Boccadoro
Mostrati risultati da 390 a 409 di 498
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile